Owens & Minor, Inc. (NYSE:OMI)‘s stock had its “market perform” rating restated by analysts at Leerink Swann in a note issued to investors on Thursday, The Fly reports. They currently have a $23.00 price objective on the stock, down from their previous price objective of $34.00. Leerink Swann’s price target points to a potential downside of 6.39% from the company’s previous close.

OMI has been the topic of several other reports. Zacks Investment Research downgraded Owens & Minor from a “hold” rating to a “sell” rating in a report on Thursday, October 12th. Robert W. Baird restated a “hold” rating and set a $28.00 price objective on shares of Owens & Minor in a report on Thursday, October 12th. BidaskClub downgraded Owens & Minor from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC restated a “hold” rating and set a $36.00 price objective on shares of Owens & Minor in a report on Friday, July 7th. Finally, UBS AG restated a “sell” rating and set a $29.50 price objective (down from $30.50) on shares of Owens & Minor in a report on Wednesday, August 9th. Four analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The stock has a consensus rating of “Sell” and an average price target of $29.75.

Owens & Minor (NYSE:OMI) last announced its earnings results on Wednesday, November 1st. The company reported $0.40 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.10). The company had revenue of $2.33 billion for the quarter, compared to analysts’ expectations of $2.40 billion. Owens & Minor had a net margin of 1.02% and a return on equity of 11.64%. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.51 earnings per share.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/02/owens-minors-omi-market-perform-rating-reaffirmed-at-leerink-swann.html.

Several hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Owens & Minor by 8,301.0% in the 1st quarter. BlackRock Inc. now owns 7,423,066 shares of the company’s stock valued at $256,840,000 after acquiring an additional 7,334,707 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Owens & Minor by 3.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,657,574 shares of the company’s stock valued at $85,547,000 after acquiring an additional 90,266 shares during the last quarter. State Street Corp increased its holdings in shares of Owens & Minor by 4.1% in the 2nd quarter. State Street Corp now owns 2,357,208 shares of the company’s stock valued at $75,880,000 after acquiring an additional 92,783 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Owens & Minor by 24.9% in the 2nd quarter. Northern Trust Corp now owns 2,110,016 shares of the company’s stock valued at $67,922,000 after acquiring an additional 421,202 shares during the last quarter. Finally, Macquarie Group Ltd. increased its holdings in shares of Owens & Minor by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 1,313,286 shares of the company’s stock valued at $42,275,000 after acquiring an additional 40,926 shares during the last quarter. Institutional investors and hedge funds own 97.27% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

The Fly

Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.